Total Pelvic Exenteration
- Author(s)
- Warrier, SK; Lynch, AC; Heriot, AG;
- Journal Title
- In: Kelly, M.E., Winter, D.C. (eds) Surgical Management of Advanced Pelvic Cancer
- Publication Type
- Book section
- Abstract
- Summary Total pelvic exenteration (TPE) involves the en-bloc removal of all the pelvic organs, namely the rectum, prostate, and bladder in male patients, and the rectum, uterus and ovaries, vagina, and bladder in female patients. Pelvic exenteration has evolved over time from a procedure that would only be considered in very selective circumstances to one that is considered to be a standard procedure in tertiary and quaternary surgical centers. Colorectal cancer is the most common indication for TPE, with 12% of rectal cancers extending beyond the fascia propria and requiring “Beyond total mesorectal excision” surgery. Every patient due to have a TPE should have an examination under anesthesia and flexible sigmoidoscopy. The majority of patients with locally advanced pelvic cancer receive neoadjuvant therapy prior to TPE. Customized flexible applicators are applied with precise delivery of a single fraction of radiotherapy to the surgical bed.
- Department(s)
- Surgical Oncology
- Publisher's Version
- https://doi.org/10.1002/9781119518495.ch10
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-05-09 06:08:20
Last Modified: 2025-05-09 06:09:24